Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0 0
Stock impact report

Allakos: Successful Midstage Trial Leads To Too High A Valuation [Seeking Alpha]

Allakos, Inc (ALLK)  More Company Research Source: Seeking Alpha
Last allakos, inc earnings: 11/12 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.allakos.com/investor-relations
PDF Allakos: Successful Midstage Trial Leads To Too High A Valuation Allakos ( ALLK refers Last year, around the time of its IPO, somebody said that $40 is too high a price to pay for ALLK because it didn’t have a product and was far away from the market. So, we need to figure out: why was he proven wrong, and what makes this stock tick? Is this movement sustainable? Can new investors get a better entry price? How would the stock’s potential be like nearing approval? It seems that the principal support behind ALLK has been its proximity to Roche ( OTCQX:RHHBY AZN AK002 can get first past the post in getting orphan drug designation and perhaps a fast track. The company took advantage of the recent positive data readout and upsized the originally planned $200 million worth of shares to $350 million worth of shares. The market also moved high enough for it to price the offering at $77, slightly below the market bid. The next two years will see a catalyst every 4-5 months. Catalyst Top line d [Read more]
Impact snapshot Event time: ALLK
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last price
VWAP
High:
Max up
High:
Low:
Max down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Opt-in for
ALLK alerts
from News Quantified
Opt-in for
ALLK alerts

from News Quantified
Opt-in for
ALLK alerts

from News Quantified